Dina Kao, MD
University of Alberta
8
8
7
N/A
0
4
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
+2 more interventions
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (8)
Research Network
Collaboration Network
Research Areas & Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Eoin Lalor
University of Alberta
Shared therapeutic areas:
Worked with same sponsors:
Sabine Hazan, MD
ProgenaBiome
Shared therapeutic areas:
Shivan Mehta, MD
University of Pennsylvania
Shared therapeutic areas:
Danny de Looze, Professor
Gent University Hospital
Shared therapeutic areas:
Max Reinshagen, Professor
Kinikum Braunschweig
Shared therapeutic areas:
Javier Pérez Gisbert, MD
Hospital La Princesa, Madrid
Shared therapeutic areas:
Yoram Bouhnik, MD
Hôpital Beaujon, Clichy
Shared therapeutic areas:
Joaquín Hinojosa de Val, MD
Hospital de Manises, Valencia
Shared therapeutic areas:
Hamid Gourabi, PhD
head of Royan Institute
Shared therapeutic areas:
emilie garrido pradalie
APHM
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (8)
Showing 8 of 8 trials
Multicentre Blinded Comparison of Lyophilized Sterile Fecal Filtrate to Lyophilized Fecal Microbiota Transplant in Recurrent Clostridioides Difficile Infection
Fecal Microbiota Transplant (FMT) Plus Fidaxomicin for Severe or Fulminant Clostridium Difficile Infection
Lyophilized Fecal Transplant vs Lyophilized Fecal Filtrate in Recurrent C Diff Infection
FMT Delivered by Capsule Versus Colonoscopy for Recurrent C. Diff
A Trial Comparing Propofol to Midazolam Plus Meperidine Sedation for Outpatient Colonoscopy
Fecal Microbiota Transplantation (FMT) in the Management of Active Crohn's Disease
Fecal Microbiota Transplantation (FMT) in the Management of Active Ulcerative Colitis
All 8 trials loaded